Shalby's board approved Q3 financial results: Consolidated revenue ₹272.13 Cr, profit ₹1.77 Cr (EPS ₹0.12). Re-appointed Mr. Shyamal Joshi as Independent Director, pending shareholder vote. Also, approved ₹59.60 Cr investment in subsidiary PK Healthcare's rights issue.